Back to Search Start Over

Insights from an observational translational research program during the COVID-19 pandemic: Four years of experience.

Authors :
Rowe M
Collier AY
Barouch DH
Source :
Vaccine [Vaccine] 2024 Oct 24; Vol. 42 (24), pp. 126306. Date of Electronic Publication: 2024 Sep 05.
Publication Year :
2024

Abstract

The COVID-19 Biorepository at Beth Israel Deaconess Medical Center in Boston was initiated in 2020 to address questions about COVID-19 infection and vaccination in a time of urgent need. From April 2020 through July 2024, we enrolled 1018 participants and collected thousands of biospecimens. We enrolled participants from the general population as well as from specific populations that were not well represented in clinical trials, including immunosuppressed, pregnant, and lactating individuals. Our observational study was designed to accommodate the rapidly changing landscape of the pandemic, including the introduction of new vaccines and boosters, breakthrough infections, and emerging variants. Reflecting on the past four years of this experience, we believe that teamwork, collaboration, and flexibility were key factors for the success of this effort, which generated data in real time about COVID-19 vaccine responses in multiple populations, hybrid immunity following breakthrough infections, immune evasion of emerging variants, and immune imprinting following booster immunizations. Rapid dissemination of data through preprints, peer-reviewed publications, and public communications allowed for the real time use of our findings to address public health issues and to inform vaccine policies. The dedication of the study participants, clinical investigators, and laboratory investigators made this research program possible.<br />Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Dan Barouch reports financial support was provided by Massachusetts Consortium on Pathogen Readiness. Dan Barouch, Ai-ris Collier reports financial support was provided by National Institutes of Health. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024. Published by Elsevier Ltd.)

Details

Language :
English
ISSN :
1873-2518
Volume :
42
Issue :
24
Database :
MEDLINE
Journal :
Vaccine
Publication Type :
Academic Journal
Accession number :
39241351
Full Text :
https://doi.org/10.1016/j.vaccine.2024.126306